Viewing Study NCT02644460


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-02-25 @ 8:30 PM
Study NCT ID: NCT02644460
Status: COMPLETED
Last Update Posted: 2023-10-26
First Post: 2015-12-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors
Sponsor: Emory University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Intrinsic Pontine Glioma View
None Brain Tumor, Recurrent View
None Solid Tumor, Recurrent View
None Neuroblastoma, Recurrent, Refractory View
None Ewing Sarcoma, Recurrent, Refractory View
None Rhabdomyosarcoma, Recurrent, Refractory View
None Osteosarcoma, Recurrent, Refractory View
None Rhabdoid Tumor, Recurrent, Refractory View
Keywords: